FibroGen, Inc. (BMV:FGEN)
205.00
-5.00 (-2.38%)
At close: Oct 9, 2025
FibroGen Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2013 - 2019 |
Cash & Equivalents | 23.37 | 50.48 | 81.55 | 155.7 | 171.22 | 678.39 | Upgrade |
Short-Term Investments | - | - | 121.9 | 266.31 | 233.97 | 8.14 | Upgrade |
Cash & Short-Term Investments | 23.37 | 50.48 | 203.45 | 422.01 | 405.19 | 686.54 | Upgrade |
Cash Growth | -83.39% | -75.19% | -51.79% | 4.15% | -40.98% | 28.62% | Upgrade |
Accounts Receivable | 0.14 | 0.48 | 5.12 | - | - | - | Upgrade |
Other Receivables | - | - | - | 16.3 | 17.4 | 41.88 | Upgrade |
Total Trade Receivables | 0.14 | 0.48 | 5.12 | 16.3 | 17.4 | 41.88 | Upgrade |
Inventory | 3.86 | 3.16 | 17.17 | 40.44 | 31.02 | 16.53 | Upgrade |
Other Current Assets | 134.96 | 142.39 | 105.81 | 14.08 | 20.45 | 10.16 | Upgrade |
Total Current Assets | 162.32 | 196.51 | 331.56 | 492.83 | 474.06 | 755.11 | Upgrade |
Net Property, Plant & Equipment | - | - | 69.72 | 100.5 | 119.39 | 65.3 | Upgrade |
Long-Term Investments | - | - | - | 9.41 | 171.62 | 2.97 | Upgrade |
Other Long-Term Assets | 15.73 | 18.02 | 22.25 | 7.35 | 8.75 | 3.46 | Upgrade |
Total Assets | 178.06 | 214.53 | 423.53 | 610.09 | 773.82 | 826.84 | Upgrade |
Accounts Payable | 10.48 | 5.06 | 15.78 | 30.76 | 26.1 | 24.79 | Upgrade |
Accrued Expenses | 35.92 | 62.04 | 132.99 | 219.77 | 172.6 | 118.33 | Upgrade |
Current Portion of Long-Term Debt | 73.73 | - | - | - | - | - | Upgrade |
Current Portion of Leases | - | - | 12.65 | 10.29 | 10.94 | 13.52 | Upgrade |
Unearned Revenue | 27.31 | 27.29 | 12.74 | 12.74 | 15.86 | 6.55 | Upgrade |
Other Current Liabilities | 8.46 | 38.92 | 43.52 | - | - | - | Upgrade |
Total Current Liabilities | 155.9 | 133.31 | 217.67 | 273.56 | 225.5 | 163.19 | Upgrade |
Long-Term Debt | - | 73.09 | 71.93 | - | - | - | Upgrade |
Long-Term Leases | - | - | 65.03 | 79.59 | 88.78 | 26.24 | Upgrade |
Other Long-Term Liabilities | 203.19 | 191.76 | 231.09 | 258.41 | 230.44 | 195.96 | Upgrade |
Total Long-Term Liabilities | 203.19 | 264.85 | 368.06 | 338.01 | 319.21 | 222.2 | Upgrade |
Total Liabilities | 359.09 | 398.16 | 585.73 | 611.57 | 544.71 | 385.39 | Upgrade |
Common Stock | 1.01 | 1.01 | 0.99 | 0.94 | 0.93 | 0.91 | Upgrade |
Additional Paid-in Capital | 1,673 | 1,669 | 1,644 | 1,541 | 1,476 | 1,400 | Upgrade |
Accumulated Other Comprehensive Income | -4.79 | -5.73 | -6.88 | -5.72 | -4.16 | -4.5 | Upgrade |
Retained Earnings | -1,892 | -1,889 | -1,842 | -1,558 | -1,264 | -974.01 | Upgrade |
Total Common Shareholders' Equity | -223 | -225.6 | -204.17 | -21.45 | 209.15 | 422.18 | Upgrade |
Minority Interest | 41.97 | 41.97 | 41.97 | 19.97 | 19.97 | 19.27 | Upgrade |
Shareholders' Equity | -181.03 | -183.64 | -162.2 | -1.48 | 229.11 | 441.45 | Upgrade |
Total Liabilities & Equity | 178.06 | 214.53 | 423.53 | 610.09 | 773.82 | 826.84 | Upgrade |
Total Debt | 73.73 | 73.09 | 149.61 | 89.89 | 99.72 | 39.76 | Upgrade |
Net Cash (Debt) | -50.37 | -22.61 | 53.84 | 332.12 | 305.47 | 646.78 | Upgrade |
Net Cash Growth | - | - | -83.79% | 8.72% | -52.77% | 33.69% | Upgrade |
Net Cash Per Share | -12.49 | -5.65 | 13.83 | 88.72 | 82.69 | 179.95 | Upgrade |
Book Value | -223 | -225.6 | -204.17 | -21.45 | 209.15 | 422.18 | Upgrade |
Book Value Per Share | -55.29 | -56.38 | -52.46 | -5.73 | 56.62 | 117.46 | Upgrade |
Tangible Book Value | -223 | -225.6 | -204.17 | -21.45 | 209.15 | 422.18 | Upgrade |
Tangible Book Value Per Share | -55.29 | -56.38 | -52.46 | -5.73 | 56.62 | 117.46 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.